Erik Billings - Concepedia

Author

Erik Billings

Walter Reed Army Institute of Research ORCID

Also Known As

Billings E., Billings, Erik Antonio, E Billings, E. Billings, Erik A Billings, Erik A. Billings, Erik Billings, Erik A. Billings, Maganga, Lucas

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research National Institutes of Health National Institute of Allergy and Infectious Diseases Duke Medical Center Henry M. Jackson Foundation

About

Erik Billings is an author at Walter Reed Army Institute of Research specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.5K
2	Epidemiology	3	3	48
3	Global Health	3	3	48
4	Public Health	2	2	33
5	Natural Sciences	1	1	15

Erik Billings

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Barton F. Haynes, Peter B. Gilbert, M. Juliana McElrath, New England Journal of Medicine	2012	1.8K
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys Dan H. Barouch, Jinyan Liu, Hualin Li, Nature VaccinationVaccine DevelopmentVaccine ResearchRhesus MonkeysImmunology	2012	454
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys Dan H. Barouch, Kathryn E. Stephenson, Erica N. Borducchi, Cell VaccinationProtective EfficacyVaccine DevelopmentHeterologous Shiv ChallengesRhesus Monkeys	2013	337
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120 Nicos Karasavvas, Erik Billings, Mangala Rao, AIDS Research and Human Retroviruses VaccinationHiv-1 AcquisitionAntibody ResponsesVaccine TargetHuman Retrovirus	2012	210
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition Monica Vaccari, Shari N. Gordon, Slim Fourati, Nature Medicine Adaptive Immune SystemPathogenesisImmunologyAdjuvant-dependent InnateInnate Immune System	2016	203
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial Susan Zolla‐Pazner, Allan C. deCamp, Timothy Cardozo, PLoS ONE ImmunodeficienciesImmunologyImmunodominanceImmunotherapeuticsImmune System	2013	189
Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIV <sub>mac251</sub> Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial Poonam Pegu, Monica Vaccari, Shari N. Gordon, Journal of Virology	2012	133
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection Gustavo H. Kijak, Eric Sanders‐Buell, Agnès-Laurence Chenine, PLoS Pathogens Rapid ShiftsImmunologyViral DynamicPathologyGenomics	2017	59
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition Shari N. Gordon, Namal P. M. Liyanage, Melvin N. Doster, The Journal of Immunology	2016	36
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men Erik Billings, Gustavo H. Kijak, Eric Sanders‐Buell, JAIDS Journal of Acquired Immune Deficiency Syndromes	2019	21

Page 1